Serum CA 15.3, CEA and ESR Patterns in Breast Cancer
Open Access
- 1 October 1997
- journal article
- research article
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 12 (4) , 168-173
- https://doi.org/10.1177/172460089701200406
Abstract
Serum CA 15.3, CEA and ESR were longitudinally determined in 298 patients with breast cancer during postsurgical follow-up and/or therapy. Observation lasted until the death of the patient or at least for three years. With regard to longitudinal serum markers and ESR curves, four different patterns have been identified: pattern I: the markers and ESR stayed at normal levels; pattern II: the markers and ESR decreased from a peak level; pattern III: the markers and ESR fluctuated widely; pattern IV: the markers and ESR increased steadily. We have looked at overall survival (OS) and relapse-free survival (RFS) versus longitudinal CA 15.3, CEA and ESR patterns. Univariate Cox regression analysis showed that OS and RFS were significantly associated with all four patterns.Keywords
This publication has 25 references indexed in Scilit:
- Prospective confirmation of a biochemical index for measuring therapeutic efficacy in metastatic breast cancer in a multicentre studyThe Breast, 1996
- Carcinoembryonic antigen expression in stages I and II breast cancer: Its relationship with clinicopathologic factorsHuman Pathology, 1996
- Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of diseaseEuropean Journal Of Cancer, 1994
- CA 15.3 determination in patients with breast cancer: Clinical utility for the detection of distant metastasesEuropean Journal Of Cancer, 1993
- Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic diseaseCancer, 1989
- Serum CA 15-3 assay in the diagnosis and follow-up of breast cancerBritish Journal of Cancer, 1988
- Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.Journal of Clinical Oncology, 1987
- Serum carcinoembryonic antigen in the diagnosis and prognosis of women with breast cancerEuropean Journal of Cancer and Clinical Oncology, 1984
- Management and survival of female breast cancer: Results of a national survey by the American college of surgeonsCancer, 1980
- On the Diagnosis and Treatment of Breast CancerPublished by American Medical Association (AMA) ,1979